GSF
AMGN icon

Grove Street Fiduciary’s Amgen AMGN Stock Holding History

Grove Street Fiduciary’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Hold
671
– – 0.1% 68
2026
Q1 		$236K Hold
671
– – 0.1% 65
2025
Q4 		$220K Buy
+671
New +$213K 0.09% 70
2025
Q2 		– Sell
-671
Closed -$209K – 74
2025
Q1 		$209K Buy
+671
New +$198K 0.11% 67

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Grove Street Fiduciary's AMGN Position: Q2 2026 in Review

Grove Street Fiduciary held its Amgen (AMGN) position steady in Q2 2026 at 671 shares worth $243K. The position accounts for 0.1% of the portfolio, ranked #68.

Grove Street Fiduciary first reported a position in AMGN in Q1 2025 and has held it in 4 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Grove Street Fiduciary held 671 shares of Amgen worth $243K as of Q2 2026.
  • Grove Street Fiduciary left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.1% of Grove Street Fiduciary's portfolio in Q2 2026, its #68 holding.
  • Grove Street Fiduciary first reported a position in Amgen in Q1 2025 and has held it in 4 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Grove Street Fiduciary's 13F filing for Q2 2026, filed 23 Jul 2026.